GL Pharm Tech Corp. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
175
196
1,084
5,494
4,237
Depreciation, Depletion & Amortization
201
157
195
275
401
Other Funds
82
105
-
21
-
Funds from Operations
476
824
1,238
2,332
3,296
Changes in Working Capital
297
1,034
1,165
1,662
524
Net Operating Cash Flow
773
210
2,404
3,994
3,820
Capital Expenditures
450
762
446
482
772
Sale of Fixed Assets & Businesses
-
13
-
-
-
Purchase/Sale of Investments
1,183
602
3,305
5,770
2,319
Net Investing Cash Flow
726
1,355
4,059
5,467
3,007
Cash Dividends Paid - Total
9
9
-
-
-
Issuance/Reduction of Debt, Net
397
529
330
1,660
6,605
Net Financing Cash Flow
324
625
2,170
1,639
6,605
Net Change in Cash
1,175
941
515
166
222
Free Cash Flow
764
409
1,961
4,430
4,497
Other Sources
4
19
111
550
137
Change in Capital Stock
-
-
2,500
-
-
Other Uses
12
23
418
371
53
About GL Pharm Tech
View Profile
